| Patient | Elisabeth of Austria |
|---|---|
| Date of birth | 1837-12-24 |
| Identifiers | MRN HR-NI030-SYN-TD; SSN (made up) 000-30-5817 |
| Document date | 2026-11-01 |
| Author | Adelheid Marchetti-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for weight loss, fatigue, ankle swelling and dizziness: history, examination with orthostatic vital signs, ECG, blood tests, depression and safety screening, a start to nutrition with thiamine, and an eating disorders psychiatry referral. Concerns: She is frightened of gaining weight and of losing control of her body, but is exhausted and dizzy and knows she cannot go on like this; She does not want anyone, including clinic staff, to discuss her weight or her visits, and fears her illness becoming public; She cannot stay in one place for long and will be travelling for weeks at a time. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal plan | once daily for 14 days | Oral route | 1894-02-03 to 1894-02-17 | completed | S |
| Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily | once daily | Oral route | 1894-02-03 | active | S |
| Potassium chloride 20 mEq extended-release tablet, one by mouth daily with food for three days | once daily for three days | Oral route | 1894-05-26 to 1894-05-28 | completed | S |
| Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weeks | twice daily with meals | Oral route | 1894-02-10 to 1894-03-03 | completed | S |
| Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal | once daily with a meal | Oral route | 1894-03-03 | active | S |
| Sertraline 25 mg tablet, one by mouth each morning for two weeks | once daily in the morning | Oral route | 1894-03-03 to 1894-03-17 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 1894-03-17 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Resting twelve-lead electrocardiogram | 1894-02-03 to 1894-02-03 | completed | S |
| Advance care planning conversation, about 20 minutes | 1894-03-24 to 1894-03-24 | completed | S |
| Resting twelve-lead electrocardiogram | 1894-05-26 to 1894-05-26 | completed | S |
| Dual-energy X-ray absorptiometry (DXA) of the lumbar spine and hip | 1894-03-03 to 1894-03-03 | completed | S |
| Resting twelve-lead electrocardiogram | 1894-03-03 to 1894-03-03 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1894-03-24 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
| 1894-03-24 | Pneumococcal conjugate vaccine (PCV20) | completed | S |
| 1894-03-24 | Tdap vaccine | completed | S |
| 1894-06-30 | Recombinant zoster vaccine, dose 2 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| her early twenties | A prolonged illness in early adulthood with cough, poor nutrition, anemia and exhaustion, which improved with time away by the sea | D (CLM-0003) |
| since her late teens | Restrictive dieting since early adulthood, with single-food meals, a fixed upper weight of 50 kg, tight lacing to a waist of about 50 cm, and hours of walking and gymnastics every day | D (CLM-0005, CLM-0006, CLM-0007) |
| her forties | Gave up horse riding in her forties because of health problems not specified in the cited source | D (CLM-0007) |
| recent years | Swelling, bodily pains and sciatica in recent years, called hunger edema in letters from a spa | D (CLM-0008, CLM-0010) |
| January 1889 | Mourning and deepening depression since the death of her son five years ago | D (CLM-0012, CLM-0013) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| She is frightened of gaining weight and of losing control of her body, but is exhausted and dizzy and knows she cannot go on like this | active | S |
| She does not want anyone, including clinic staff, to discuss her weight or her visits, and fears her illness becoming public | active | S |
| She cannot stay in one place for long and will be travelling for weeks at a time | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 12.4 on 1894-04-28; MCV [Entitic mean volume] in Red Blood Cells by Automated count 93 on 1894-02-03; Leukocytes [#/volume] in Blood by Automated count 4.4 on 1894-04-28; Platelets [#/volume] in Blood by Automated count 168 on 1894-02-03; Sodium [Moles/volume] in Serum or Plasma 138 on 1894-06-30; Potassium [Moles/volume] in Serum or Plasma 4.1 on 1894-06-30; Urea nitrogen [Mass/volume] in Serum or Plasma 24 on 1894-05-26; Creatinine [Mass/volume] in Serum or Plasma 0.78 on 1894-05-26; Glucose [Mass/volume] in Serum or Plasma 80 on 1894-03-03; Magnesium [Mass/volume] in Serum or Plasma 2 on 1894-06-30; Phosphate [Mass/volume] in Serum or Plasma 3.6 on 1894-06-30; Albumin [Mass/volume] in Serum or Plasma 4.1 on 1894-02-03; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 on 1894-04-28; Thyrotropin [Units/volume] in Serum or Plasma 2.2 on 1894-02-03; C reactive protein [Mass/volume] in Serum or Plasma 1 on 1894-02-03; Tissue transglutaminase IgA Ab [Units/volume] in Serum 0.8 on 1894-02-03; Ferritin [Mass/volume] in Serum or Plasma 64 on 1894-02-03; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1894-06-30; Q-T interval corrected 436 on 1894-03-03; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1889)/1.73 sq M 89 on 1894-05-26; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 on 1894-06-30; DXA Lumbar spine [T-score] Bone density -2.1 on 1894-03-03; DXA Femur [T-score] Bone density -1.8 on 1894-03-03; Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment 6.8 on 1894-03-03; Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment 1.2 on 1894-03-03 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requested | resolved | confirmed | R63.4 | S — Synthetic presenting problem anchored to her documented restrictive eating, low weight and swelling; superseded by the diagnosis at the consultation. |
| Anorexia nervosa, restricting type, moderate (DSM-5-TR), with compulsive exercise and frequent self-weighing, beginning in early adulthood; complicated at diagnosis by sinus bradycardia, orthostatic dizziness, ankle edema, mild anemia and leukopenia, low glucose, raised ALT and low phosphate after refeeding began | active | confirmed | F50.011 | S — Synthetic modern diagnosis made at the consultation, linked to her documented restrictive eating and exercise and to the retrospective diagnosis of anorexia nervosa (R). |
| Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intake | active | confirmed | F33.1 | S — Synthetic modern diagnosis linked to her documented mourning and ever-deepening depressions; not a claim that she was so diagnosed. |
| Acute viral gastroenteritis, caught from a member of her travelling party, with mild dehydration, orthostatic hypotension and mild hypokalemia; no purging behavior; managed with oral rehydration and potassium; resolved | resolved | confirmed | A08.4 | S — Synthetic acute problem; not a historical claim. |
| Low bone mass (osteopenia) of the lumbar spine and hip after decades of low weight: lumbar spine T-score -2.1, femoral neck T-score -1.8; FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture; no fractures | active | confirmed | M85.80 | S — Synthetic modern finding on DXA; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1894-02-03 | Hemoglobin [Mass/volume] in Blood | 11.2 | g/dL | 12-15.5 g/dL | Low | S |
| 1894-02-03 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 93 | fL | 80-100 fL | Normal | S |
| 1894-02-03 | Leukocytes [#/volume] in Blood by Automated count | 3.4 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 1894-02-03 | Platelets [#/volume] in Blood by Automated count | 168 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1894-02-03 | Sodium [Moles/volume] in Serum or Plasma | 136 | mmol/L | 135-145 mmol/L | Normal | S |
| 1894-02-03 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1894-02-03 | Urea nitrogen [Mass/volume] in Serum or Plasma | 21 | mg/dL | 7-20 mg/dL | High | S |
| 1894-02-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.56 | mg/dL | 0.59-1.04 mg/dL | Low | S |
| 1894-02-03 | Glucose [Mass/volume] in Serum or Plasma | 68 | mg/dL | 70-99 mg/dL | Low | S |
| 1894-02-03 | Magnesium [Mass/volume] in Serum or Plasma | 1.8 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-02-03 | Phosphate [Mass/volume] in Serum or Plasma | 3 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1894-02-03 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 1894-02-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 52 | U/L | 7-35 U/L | High | S |
| 1894-02-03 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1894-02-03 | C reactive protein [Mass/volume] in Serum or Plasma | 1 | mg/L | <=5 mg/L | Normal | S |
| 1894-02-03 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 0.8 | U/mL | Below 4.0 is negative | Normal | S |
| 1894-02-03 | Ferritin [Mass/volume] in Serum or Plasma | 64 | ng/mL | 15-150 ng/mL | Normal | S |
| 1894-02-03 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 22 | ng/mL | 30-100 ng/mL | Low | S |
| 1894-02-03 | Q-T interval corrected | 438 | ms | Above 460 ms is prolonged in women | Normal | S |
| 1894-02-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1889)/1.73 sq M | 107 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1894-02-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | {score} | S | ||
| 1894-03-24 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 13 | {score} | S | ||
| 1894-05-26 | Sodium [Moles/volume] in Serum or Plasma | 134 | mmol/L | 135-145 mmol/L | Low | S |
| 1894-05-26 | Potassium [Moles/volume] in Serum or Plasma | 3.3 | mmol/L | 3.5-5.1 mmol/L | Low | S |
| 1894-05-26 | Urea nitrogen [Mass/volume] in Serum or Plasma | 24 | mg/dL | 7-20 mg/dL | High | S |
| 1894-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1894-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1889)/1.73 sq M | 89 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1894-05-26 | Glucose [Mass/volume] in Serum or Plasma | 72 | mg/dL | 70-99 mg/dL | Normal | S |
| 1894-05-26 | Magnesium [Mass/volume] in Serum or Plasma | 1.7 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-05-26 | Phosphate [Mass/volume] in Serum or Plasma | 3 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1894-05-26 | Q-T interval corrected | 452 | ms | Above 460 ms is prolonged in women | Normal | S |
| 1894-02-10 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1894-02-10 | Potassium [Moles/volume] in Serum or Plasma | 3.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1894-02-10 | Glucose [Mass/volume] in Serum or Plasma | 74 | mg/dL | 70-99 mg/dL | Normal | S |
| 1894-02-10 | Magnesium [Mass/volume] in Serum or Plasma | 1.8 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-02-10 | Phosphate [Mass/volume] in Serum or Plasma | 2.3 | mg/dL | 2.5-4.5 mg/dL | Low | S |
| 1894-03-03 | Hemoglobin [Mass/volume] in Blood | 11.9 | g/dL | 12-15.5 g/dL | Low | S |
| 1894-03-03 | Leukocytes [#/volume] in Blood by Automated count | 3.9 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 1894-03-03 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1894-03-03 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1894-03-03 | Glucose [Mass/volume] in Serum or Plasma | 80 | mg/dL | 70-99 mg/dL | Normal | S |
| 1894-03-03 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-03-03 | Phosphate [Mass/volume] in Serum or Plasma | 3.2 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1894-03-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 7-35 U/L | High | S |
| 1894-03-03 | Q-T interval corrected | 436 | ms | Above 460 ms is prolonged in women | Normal | S |
| 1894-03-03 | DXA Lumbar spine [T-score] Bone density | -2.1 | {T-score} | -1.0 or higher is normal; -2.5 or lower is osteoporosis | Low | S |
| 1894-03-03 | DXA Femur [T-score] Bone density | -1.8 | {T-score} | -1.0 or higher is normal; -2.5 or lower is osteoporosis | Low | S |
| 1894-03-03 | Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment | 6.8 | % | S | ||
| 1894-03-03 | Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment | 1.2 | % | S | ||
| 1894-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | {score} | S | ||
| 1894-04-28 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 12-15.5 g/dL | Normal | S |
| 1894-04-28 | Leukocytes [#/volume] in Blood by Automated count | 4.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1894-04-28 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1894-04-28 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1894-04-28 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-04-28 | Phosphate [Mass/volume] in Serum or Plasma | 3.4 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1894-04-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 7-35 U/L | Normal | S |
| 1894-04-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 10 | {score} | S | ||
| 1894-06-30 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1894-06-30 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1894-06-30 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1894-06-30 | Phosphate [Mass/volume] in Serum or Plasma | 3.6 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1894-06-30 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | 30-100 ng/mL | Normal | S |
| 1894-06-30 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1894-02-03 | Body height | 172 | cm | S |
| 1894-02-03 | Body weight | 47.4 | kg | S |
| 1894-02-03 | Body mass index (BMI) [Ratio] | 16 | kg/m2 | S |
| 1894-02-03 | Systolic blood pressure | 96 | mm[Hg] | S |
| 1894-02-03 | Diastolic blood pressure | 62 | mm[Hg] | S |
| 1894-02-03 | Heart rate | 52 | /min | S |
| 1894-02-03 | Respiratory rate | 14 | /min | S |
| 1894-02-03 | Body temperature | 36 | Cel | S |
| 1894-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1894-02-10 | Body height | 172 | cm | S |
| 1894-02-10 | Body weight | 47.9 | kg | S |
| 1894-02-10 | Body mass index (BMI) [Ratio] | 16.2 | kg/m2 | S |
| 1894-02-10 | Systolic blood pressure | 98 | mm[Hg] | S |
| 1894-02-10 | Diastolic blood pressure | 62 | mm[Hg] | S |
| 1894-02-10 | Heart rate | 54 | /min | S |
| 1894-02-10 | Respiratory rate | 14 | /min | S |
| 1894-02-10 | Body temperature | 36.1 | Cel | S |
| 1894-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1894-03-03 | Body height | 172 | cm | S |
| 1894-03-03 | Body weight | 49.6 | kg | S |
| 1894-03-03 | Body mass index (BMI) [Ratio] | 16.8 | kg/m2 | S |
| 1894-03-03 | Systolic blood pressure | 100 | mm[Hg] | S |
| 1894-03-03 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1894-03-03 | Heart rate | 56 | /min | S |
| 1894-03-03 | Respiratory rate | 14 | /min | S |
| 1894-03-03 | Body temperature | 36.2 | Cel | S |
| 1894-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1894-04-28 | Body height | 172 | cm | S |
| 1894-04-28 | Body weight | 52 | kg | S |
| 1894-04-28 | Body mass index (BMI) [Ratio] | 17.6 | kg/m2 | S |
| 1894-04-28 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1894-04-28 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1894-04-28 | Heart rate | 60 | /min | S |
| 1894-04-28 | Respiratory rate | 14 | /min | S |
| 1894-04-28 | Body temperature | 36.4 | Cel | S |
| 1894-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1894-06-30 | Body height | 172 | cm | S |
| 1894-06-30 | Body weight | 54 | kg | S |
| 1894-06-30 | Body mass index (BMI) [Ratio] | 18.3 | kg/m2 | S |
| 1894-06-30 | Systolic blood pressure | 106 | mm[Hg] | S |
| 1894-06-30 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1894-06-30 | Heart rate | 62 | /min | S |
| 1894-06-30 | Respiratory rate | 14 | /min | S |
| 1894-06-30 | Body temperature | 36.5 | Cel | S |
| 1894-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1894-03-24 | Body height | 172 | cm | S |
| 1894-03-24 | Body weight | 50.4 | kg | S |
| 1894-03-24 | Body mass index (BMI) [Ratio] | 17 | kg/m2 | S |
| 1894-03-24 | Systolic blood pressure | 100 | mm[Hg] | S |
| 1894-03-24 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1894-03-24 | Heart rate | 58 | /min | S |
| 1894-03-24 | Respiratory rate | 14 | /min | S |
| 1894-03-24 | Body temperature | 36.3 | Cel | S |
| 1894-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1894-05-26 | Body height | 172 | cm | S |
| 1894-05-26 | Body weight | 51 | kg | S |
| 1894-05-26 | Body mass index (BMI) [Ratio] | 17.2 | kg/m2 | S |
| 1894-05-26 | Systolic blood pressure | 96 | mm[Hg] | S |
| 1894-05-26 | Diastolic blood pressure | 60 | mm[Hg] | S |
| 1894-05-26 | Heart rate | 74 | /min | S |
| 1894-05-26 | Respiratory rate | 16 | /min | S |
| 1894-05-26 | Body temperature | 37.6 | Cel | S |
| 1894-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1894-02-03 | New patient visit for weight loss, fatigue, ankle swelling and dizziness: history, examination with orthostatic vital signs, ECG, blood tests, depression and safety screening, a start to nutrition with thiamine, and an eating disorders psychiatry referral | finished | S |
| 1894-02-10 | One-week medical stabilization check and eating disorders psychiatry consultation | finished | S |
| 1894-03-03 | Four-week review: weight, vital signs, electrolytes, bone density, and depression | finished | S |
| 1894-04-28 | Twelve-week review: weight restoration, exercise, mood and sertraline | finished | S |
| 1894-06-30 | Twenty-one-week review: weight, mood, the gastroenteritis, and care while travelling | finished | S |
| 1894-03-24 | Periodic adult preventive visit | finished | S |
| 1894-05-26 | Same-day sick visit for vomiting and diarrhea | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Eating disorders psychiatry consultation in one week to confirm the diagnosis, decide the level of care, and lead a multidisciplinary plan | completed | GL-APA-ED-2023, GL-AED-MCS-2021 | S |
| Medical assessment and stabilization: orthostatic vital signs and temperature, ECG, blood count, electrolytes with phosphate and magnesium, glucose, kidney and liver tests, albumin, TSH, CRP, ferritin and vitamin D; admission criteria explained; electrolytes, phosphate and magnesium to be rechecked three to four days after the meal plan starts, then weekly for the first weeks | completed | GL-APA-ED-2023, GL-SAHM-ED-2022, GL-AED-MCS-2021 | S |
| Refeeding risk: thiamine 100 mg daily before and during the first two weeks, and a starting meal plan of about 1,600 kcal a day in three meals and two snacks, increased by about 200 to 300 kcal every few days | completed | GL-ASPEN-REFEED-2020, GL-SAHM-ED-2022 | S |
| Collaborative safety plan with warning signs, coping steps, people to contact including her travelling companion, the clinic number, the 988 Suicide & Crisis Lifeline and local emergency numbers abroad; medicines dispensed in small supplies and kept by her companion | completed | GL-SUICIDE-2024 | S |
| Privacy: the chart is flagged as restricted, access is audited, she is booked under a scheduling alias at the first or last appointment of the day, and weights are discussed only in the consulting room | completed | GL-APA-ED-2023 | S |
| Multidisciplinary outpatient treatment: weekly CBT-E with an eating disorders therapist, a dietitian twice a month, medical review by the primary clinician, and psychiatry review; open weighing at sessions instead of weighing at home; by video when she travels | completed | GL-APA-ED-2023, GL-NICE-NG69 | S |
| Compulsive exercise: no gymnastics and walks of no more than an hour a day while weight is restored and the pulse and orthostatic changes are abnormal, with a graded return agreed by the team | completed | GL-APA-ED-2023, GL-SAHM-ED-2022 | S |
| Bone health: DXA of the spine and hip, calcium 1,200 mg a day from food and supplement, vitamin D, weight restoration as the main treatment, and repeat DXA in two years | completed | GL-CMID-2026, GL-USPSTF-OST-2025, GL-APA-ED-2023 | S |
| Depression with persistent grief: grief-focused work within therapy; sertraline 25 mg daily, increased to 50 mg after two weeks, once nutrition was under way and the QTc was normal; PHQ-9 at every visit and suicide-risk review at every visit | completed | GL-CMID-2026, GL-MDD-2022, GL-SUICIDE-2024 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Medically stable for outpatient care: resting pulse 50 or more, no orthostatic dizziness, and normal potassium, phosphate, magnesium and glucose | 1894-03-03 | completed | Pulse 56, orthostatic changes resolved, electrolytes and glucose normal at four weeks | S |
| Weight gain of about 0.5 to 1 kg a week toward a body mass index of at least 18.5 | 1894-08-31 | active | From 47.4 kg (BMI 16.0) to 54.0 kg (BMI 18.3) at twenty-one weeks; still gaining | S |
| Depression response (PHQ-9 down by at least 50 percent) by six months | 1894-06-30 | completed | PHQ-9 7 at twenty-one weeks, down 56 percent from 16 | S |
| Exercise reduced to walks of an hour or less a day while weight is restored, with no gymnastics until the team agrees | 1894-04-28 | completed | Walks of about an hour a day; gymnastics stopped | S |
Structured synthetic safety assessment on 1894-02-03: current ideation present, intent absent, plan absent. Passive thoughts of death without intent, plan or past attempts; outpatient care with a collaborative safety plan that works when she travels, the 988 Suicide & Crisis Lifeline and local emergency numbers abroad, medicines dispensed in small supplies, and review at one week [S]